A structural spectroscopic study of dissociative anaesthetic methoxphenidine
Bronislav Jurásek, Patrik Fagan, Bohumil Dolenský, Natalie Paškanová, Kristýna Dobšíková, Ivan Raich, Radek Jurok, Vladimı́r Setnička, Michal Kohout, Jan Čejka, Martin Kuchař
New Journal of Chemistry January 1, 2023 DOI: 10.1039/d2nj06126k via OpenAlex
Summary
Methoxphenidine, a dissociative anesthetic related to phencyclidine, was originally patented for its potential to treat neurotoxic injury. The abstract indicates that the compound was developed with therapeutic applications in mind, specifically for addressing damage to the nervous system. No further details about its efficacy, mechanism, or clinical use are provided in this text.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Keywords | Chemistry Dissociative Local anaesthetic General anaesthetic Pharmacology |
| Citations | 6 |
| Key finding | Methoxphenidine was originally patented for its properties to treat neurotoxic injury. |
Abstract
Methoxphenidine was originally patented for its properties to treat neurotoxic injury.